Flurbiprofen (oral)

Flurbiprofen (oral)

File:Flurbiprofen.svg
Clinical data
Pregnancy category	C (U.S.), B2 (Au)
Routes of administration	Oral
ATC code	M01AE09 (WHO) M02AA19 (WHO), S01BC04 (WHO)
Pharmacokinetic data
Protein binding	> 99%
Metabolism	Hepatic (CYP2C9)
Elimination half-life	4.7-5.7 hours
Excretion	Renal
Identifiers
IUPAC name 2-(3-fluoro-4-phenyl-phenyl)propanoic acid
CAS Number	5104-49-4
PubChem CID	3394
DrugBank	APRD00753
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C15H13FO2
Molar mass	244.261 g/mol

Flurbiprofen is a member of the phenylalkanoic acid derivative family of non-steroidal anti-inflammatory drugs (NSAIDs) used to treat the inflammation and pain of arthritis. It is also known by the trade name ANSAID and marketed by Pfizer.

Flurbiprofen is also used as an active ingredient in some kinds of throat lozenges.

R-flurbiprofen is the single enantiomer of racemate flurbiprofen; this compound is currently in clinical trials for the treatment of metastatic prostate cancer, and Alzheimer's disease.

Flurbiprofen was mocked by television satirist Stephen Colbert (for its unlikely name) during an interview with Terry Gross aired on October 9, 2007 on National Public Radio's program "Fresh Air." Colbert had been taking the drug after breaking his wrist earlier that year.